Aduro BioTech Inc (NASDAQ:ADRO) has received an average recommendation of “Hold” from the nine ratings firms that are presently covering the stock, MarketBeat reports. Three investment analysts have rated the stock with a sell recommendation, one has given a hold recommendation and five have issued a buy recommendation on the company. The average 12-month price […]